Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Talk about an understated undetectable PR! Didn't even notice that news came out... a PR the day before Thanksgiving? No wonder pps didn't budge.
In any case, this is exactly along the lines of what I was expecting for this company. I am usually not very optimistic about my penny stocks (hope for the best, expect the worst), but TZMT is actually making me salivate... a little gross. Good thing I loaded up some more recently, so cheap.
Great idea for a product (one of those simple "obvious" improvements to existing products).
Great marketing strategy (free $$$ for docs, easier for patients, large existing market, gov't pays for everything -- and now with Dems in congress, the road ahead looks very yellow and shiny).
Good execution of business plan (manufacture, testing, marketing), and ON TIME (that alone differentiates this from almost all other pennies).
No b*ll$sh1t PRs. In fact, I love understated PRs. The best ones are the ones that say "we're going to be making a little money soon" when they actually mean "back up the truck, i can't carry all this dough."
Scientific advisory board is top-notch.
I better stop now. My shirt is getting wet.
11/22/2006 Quarterly period ended September 30, 2006 - FINANCIAL INFORMATION
We have determined that we are no longer a “development stage company”
For the three month period ended September 30, 2006, our revenues from such operations were $209,693.
The Company believes that revenues will increase significantly in the second quarter of fiscal year 2007”, and for the remainder of the fiscal year, for the following reasons: (a) the walk-in clinics continue to mature; (b) on October 1, 2006, we initiated new billing and collection policies for PDS Imaging, which have increased collections; and (c) sales of the Company’s STATPATCH TM Holter Monitor began during the second quarter of fiscal 2007.
”The Company believes that the foregoing will result in significantly increased revenue recognition going forward.”
Thanks for your opinion. I think you may be right. I also think that $0.13 is not realistic right now, but you never know. If it does get down there again, I'm definitely taking more. I think the next year from here on out will be very very interesting for telzuit. Unless the statpatch flops. I don't think that will happen.
Support $0.18 - the last 3 weeks we see this level of support.
Next week they have to file the Quarterly Report on Form 10-QSB. If they start to make some nice revenue it is possible that the share price goes up a little bit.
I think we are not going to see $.13 again - but I don't know !
I hope this is a little help for you. I believe in this stock and they will make revenue with this product - nothing better is on the market and they have the patents!!!
Do you think TZMT will go to 0.13 in near future?
I hope to pick up some shares at that level, but I'm no good with TA so hard for me to pick entry points for this stock.
But, from looking at their web page and and news releases it sounds like the following year will be make-it-or-break-it for the company (me being very hopeful). Haven't physically seen the product myself (except in pictures), but it looks good, and the business strategy sounds spot-on (doctors love making easy money, patients don't like to be strapped in). This might be a simplitic assessment (basically what the company says), but it makes sense to me. I'm just looking for a good entry point in the next two weeks. Anyone got a clue?
Nice job goodlive. Sometimes it is a pain to call the company--but sometimes is very worth it to do so. Very commendable, and thanks for sharing what they told you. I hope things work out for longs here.
ted
I did ask the company.
That's the answers:
"The remaining "fine tuning" will not be an extended period."
"The PR does show progress in rolling some product out to the market and also shows that even though the product may not be fine tuned, doctors are still willing to pay for it over conventional Holter systems."
I think that's good enough for me.
If they would play false they could have concealed the problem.
So far so good, yes. However, the company said nothing about meeting the requirements of the schedule going forward. Instead they said this in the heading: "Telzuit continues to fine tune product and is not yet ready for expanded roll-out of the STATPATCH System. " And, in the release: "He further noted that Telzuit has additional work to complete on the STATPATCH System, but that the current release of the product provides the same information to the physician as a traditional Holter monitor".
"Not yet ready for expanded roll-out" and "has additional work" are not reassuring to investors who want to know if they intend to stay on schedule going forward. Maybe a call to the company is advisable here. Good luck,
ted
I don't know what you talking about !!!!
This company is completely on schedule.
- Company Corporate Milestones :
The Corporate Milestone Events are:
i. by May 31, 2006, the Company shall have opened and produced revenue at 2 Clinics;
ii. by June 30, 2006, the Company shall have successfully completed a final prototype of the “Bluetooth” technology delivered by CSR;
iii. by July 31, 2006, the Company shall have (a) Successfully Tested the functionality of Bio-Patch Wireless Halter Monitor and (b) released Bio-Patch Wireless Halter Monitor to physicians for final testing;
iv. by September 30, 2006, the Company shall have opened and produced revenue at 3 Clinics;
v. by October 31, 2006, the Company shall have billed and collected revenue of at least $10,000 on the Bio-Patch Wireless Halter Monitor;
vi. by December 31, 2006, each Clinic shall have attained an annualized gross revenue run rate, based on the revenue earned during December 2006, of $350,000;
vii. by December 31, 2006, the Company shall have a Cash Burn Rate, based on operations in December 2006, equal to or less than $100,000; and
viii. by December 31, 2006, the Company shall have annualized gross revenue, based on the revenue earned during December 2006, on Bio-Patch Wireless Halter Monitor equal to or greater than $1,000,000.
I hope it works out. Still watching. It seemed to me to be potentially negative for the short term, as it gave no timetable and might seem to investors as yet another delay in a long wait.
ted
Hey Ted
This is very good news. They are now back on track with their schedule. I like how they are doing everything very carefully before the final launch of the product. They are perfecting the technology before the nationwide release.
TZMT news after the close today:
http://biz.yahoo.com/prnews/061101/nyw228.html?.v=1
ted
Check the chart of Telzuit - looks not bad !!!
http://stockcharts.com/h-sc/ui?s=TZMT&p=D&yr=0&mn=1&dy=0&id=t68995942204&a=7...
I think they will have enough money to go on !!!!
Q3 with first time $4k total revenue, it's good start. With enough cash to burn through for the next 12 months, that erases my concern of it filing for chapter 11 at least for now.
Hey Bleah
The dilution is all part of the company's growing pains. Every start up has to dilute it's share base in order to obtain financing. Without this, no company would ever be able to get going. We'll see how they issue their shares now that they have a reasonable cash position. If they continue to issue shares instead of paying cash, than I will become concerned. Until then, I won't look negatively upon the share dilution.....
TZMT Form: 10KSB Filing Date: 10/13/2006
We have begun to generate revenues from the outpatient clinic business, although they were minimal during fiscal year 2006. The acquisition of the mobile imaging business on August 1, 2006 has significantly increased revenues. As a consequence of financings we recently completed in May 2006 for an aggregate of $4,941,985 management now believes that we have sufficient cash to continue our business for at least the next twelve (12) months, and the uncertainty as to our ability to continue as a going concern has been eliminated.
I had mixed feelings about the 10k... on one hand they finally showed some revenue (even if it was puny) and had a good business plan and look to have a promising future (let's hope there is no competition however). But with all those stocks given out as payment to contractors, etc, implied dilution... which is what looked like what happened with the stock in the previous few months. I hope they don't keep diluting. Admittedly, I think the PPS probably won't move much right in the down diretion now because most of the stock is probably owned by insiders (and they probably aren't going to sell). So that is good.
They need to get the word out I think and establish a good reputation in order for their business to grow (that is my opinion of course).
I was very impressed with their 10-K
The company is obviously on its way to becoming a major player in the medical device industry. Unfortunately, the market does not realize this yet, because the company is flying below radar. I have no problems holdings this stock for the years to come, because the potential here is amazing.
TZMT Form: 10KSB Filing Date: 10/13/2006
Description of New Products
Bio-Patch Sleep Apnea Device
The Company has filed an application with the FDA for approval of a new sleep apnea device based on the Bio-Patch wireless system. Sleep apnea currently affects an estimated 12 to 25 million people in the United States. We anticipate that our new sleep apnea device will be able to assist in the diagnosis of this condition, making it much less intrusive to the patient.
Elderly Patient Wireless Monitoring System
The Company has patented a long-term monitoring device which utilizes the proprietary Bio-Patch design (the “Elderly Patient Wireless Monitor”). The Elderly Patient Wireless Monitor is designed primarily for use by patients in nursing homes and other assisted-living facilities. This product will be used to measure basic biometric data on patients and will also be able to alert staff if a patient has fallen. The patient’s data is relayed to both a PDA and a centralized computer monitor to allow the patient’s caregivers to monitor the patient with greater accuracy and efficiency. The Company anticipates that this product will be available during the beginning of 2006.
Medical Clinics
The Company has identified key personnel who possess expertise in owning, operating and building medical clinics. The Company has decided to build on this expertise, as well as the Company’s prime location in Central Florida, to target the opening of six (6) medical clinics. The Company believes that expanding its current business plan to include the operation of medical clinics may generate positive operating results and a positive cash flow. The Company hopes to create and take advantage of a synergy among the Company’s medical clinics, the Bio-Patch and the pharmaceutical companies and their chosen Clinical Research Organizations.
TZMT Form: 10KSB Filing Date: 10/13/2006
Item 2. Description of Property
Our principal executive office is currently located at 5422 Carrier Drive, Suite 306, Orlando, Florida 32819. Our premises currently occupy 2,688 square feet. We intend to expand our offices in November 2006 through the lease of an additional 2,316 square feet of space directly proximate to our current location. We believe the additional space will be sufficient to meet our expected expansion and future operating needs. The premises are utilized for general and administrative purposes and include a monitoring center that is part of the service we offer to users of the STATPATCH TM System.
TELZUIT MEDICAL TECHNOLOGIES, INC.
Form: 10KSB Filing Date: 10/13/2006
Manufacturing Capacity
We have begun the production of our STATPATCH tm utilizing third party FDA-certified contract manufacturers. Most of the components of our products are standard parts available from multiple supply sources at competitive prices. This, coupled with the significant start-up cost advantages associated with contractors, minimizes production and product costs.
Sales and Marketing
We intend to market our products and services directly to physicians and other medical care providers, and plan to also use strategic alliances with independent medical distributors. Once our heart monitoring device is ready to market, we plan to assemble an in-house sales force to promote and offer our products. We believe that a direct sales approach will enable us to maintain control over our relationship with the medical community and allow for better product feedback to take place.
Our sales staff intends to promote our products and services at regional and national conventions, medical trade shows and through professional organizations. We also intend to utilize more conventional means to market and promote our products and services, such as advertisements through medical publications, press releases, direct mail, internet web sites and product samples.
Pricing Strategy
Our revenues are anticipated to come primarily through reimbursements from Medicare and insurance providers for the monitoring and information collecting services that we will provide. Current Medicare and most insurance coverage provides reimbursements for heart monitoring and analysis, heart activity recording and patient activation services. We may also sell the STATPATCH TM System to medical practices and payors of medical care.
Physicians who prescribe heart-monitoring devices also receive reimbursements from Medicare and insurance providers for patient hook-up, patient evaluation, and data review services they provide.
I think it's important to be patient with this company. Having said that though, I would like to hear something from the company providing some insight into Doctor's comments on the STATPATCH. If the feedback is successful, I think revenues will quickly follow. Hopefully we will have an idea of the company's future by the end of the year.....
I am waiting every day for a press releaese or a SEC filing.
Last INFO was August - it's time to tell the people how the company is doing !!!!!!!!
Financial ending 6/30/2006 is due 10/12/2006, but there are no news.
Hopefully they can release some revenue on the Statpatch in October !!??
We would need it so the stockprice goes up.
It's been awfully quiet these past couple months. We were seeing floods of press releases and now we've heard nothing. I hope the company has something good (or at least something) to announce soon.....
Oct 06, 2006 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been on the NASDAQ, AMEX and NYSE naked short threshold list for 13 consecutive trading days: Telzuit Medical Technologies, Inc. (OTCBB: TZMT), Empire State Bank (OTCBB: ESBS).
For a complete list of companies on the naked short list please visit our web site. To find the SqueezeTrigger Price before a short squeeze starts in any stock, go to
www.buyins.net.
With 31.22 million shares outstanding and 120,065 shares declared short as of September 2006, the failure to deliver in shares of TZMT has not been resolved and a buy-in is imminent.
For your sake I hope you are right. For mine, I will keep watching. :) take care,
ted
Hi Ted
I don't think the dilution will be looked down upon too much. I think people understand that this is a startup company and need to raise money through potentially dilutive means. The company couldn't have issued debt, because they don't have the cashflow to service it. The only options were the warrants and convertibles, which they used. The most important thing now is to see the doctor's feedback to the STATPATCH.
Hi Gotzmt,
The delay surely must be a big factor also. Good point. I do think that the speed and extent of the dilution is a factor that MAY keep demand down, but then again others may like the story and potential enough to look beyond it and the threat of more.. Best of luck here.
ted
I agree with you, but I don't think this is the main reason for the drop. The biggest issue for the company was the delay in releasing the product last year. This is why the stock fell from $2 to $0.15. I think at this point, even with the dilution from the warrants and convertibles, this is a good time to buy this stock.
TMZT's decline is perhaps due to the significant dilution this year, found in the SB-2 filings. My understanding from the company is that outstanding shares is now somewhere around $80 million. 10K is due out in a week or so. I am curious as to what the cash level is now. It was close to zero last 10Q, but then they did the convertible. However, their burn rate has been so high, who knows what it may be at now? I like the concept, but these factors are keeping me on the sidelines, and (I think) can account for the share price drop. Yahoo says the market cap is between 5-6 million, but it is actually double that.
ted
Any idea when the info from the Doctor's test runs will be released? If successful, this will be great news for the company and future prospects.
I've been following TZMT since June and haven't seen anything (really)but,good things.Waiting for news on the Dr. testing of the patch.
139k sounds low. I thought it would be closer to 1 million. Nevertheless, hopefully the company comes out with good news and causes the shorts to cover. It's been very quiet for the past month, would could be very good or bad. We'll see.....
BUYINS.NET: TZMT Have Also Been Added To Naked Short List Today
Sep 20, 2006 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET, www.buyins.net, announced today that these select companies have been added to the NASDAQ, AMEX and NYSE naked short threshold list: Resource Capital Corp (NYSE: RSO), Telzuit Medical Technologies, Inc. (OTCBB: TZMT), Continental Beverage and Nutrition, Inc. (OTCBB: COBN), Empire State Bank (OTCBB: ESBS), Global Matrechs, Inc. (OTCBB: GBMR), Points International Ltd. (OTCBB: PTSEF).
Telzuit was founded in 2000 and is based in Orlando, Florida. With 31.22 million shares outstanding and 139,016 shares declared short as of August 2006, there is a failure to deliver in shares of TZMT.
Trading is pretty pathetic....
It looks like everyone who once liked this stock has bailed. Also, it looks like over the past month there has been some naked short selling going on. How can this be done on an OTC stock?
You can find it - SEC filing 8-K 5/31/2006
Hi
I'm new to the board. Where did you find this list of corporate milestones?
Thanks
Today MM's playing with stock again - short selling.
vol. over 300,000 down up to .15 , close .17
What a shame, the company did not fail until todays milestone.
IMO: Share price should be over .70
Company to Obtain Certain Corporate Milestones
i. by May 31, 2006, the Company shall have opened and produced revenue at 2 Clinics
ii. by June 30, 2006, the Company shall have successfully completed a final prototype of the “Bluetooth” technology delivered by CSR;
iii. by July 31, 2006, the Company shall have (a) Successfully Tested the functionality of Bio-Patch Wireless Halter Monitor and (b) released Bio-Patch Wireless Halter Monitor to physicians for final testing;
iv. by September 30, 2006, the Company shall have opened and produced revenue at 3 Clinics;
v. by October 31, 2006, the Company shall have billed and collected revenue of at least $10,000 on the Bio-Patch Wireless Halter Monitor;
vi. by December 31, 2006, each Clinic shall have attained an annualized gross revenue run rate, based on the revenue earned during December 2006, of $350,000;
vii. by December 31, 2006, the Company shall have a Cash Burn Rate, based on operations in December 2006, equal to or less than $100,000; and
viii. by December 31, 2006, the Company shall have annualized gross revenue, based on the revenue earned during December 2006, on Bio-Patch Wireless Halter Monitor equal to or greater than $1,000,000.
Up 60% from .20 low. Nice, very nice.
Still think there is something here!
Telzuit Medical Technologies, Inc. Engages New Independent Auditors BDO Seidman Alliance Member Cross, Fernandez & Riley LLP
August 1, 2006: 10:42 a.m. EST
ORLANDO, Fla. (PRNewswire) -
ORLANDO, Fla., Aug. 1 /PRNewswire-FirstCall/ -- Telzuit Medical Technologies, Inc. announced today that the audit committee of the Company's Board of Directors has selected the accounting firm Cross, Fernandez & Riley LLP as their new independent auditor.
Telzuit reassessed their independent auditor relationship as they were approaching product launch. Jerry Balter, CFO of Telzuit commented, "We simply needed to retain a firm with an Orlando presence and with the available resources to support the Company's business requirements while ensuring we received the finest audit support available. Cross, Fernandez & Riley has a solid reputation for professionalism and service with proven expertise with public companies. When you add in their membership is the BDO Seidman Alliance, this is clearly the best choice for us at this stage."
Completion of the testing and release to physician testing is a scheduled milestone required under recent financing terms
The latest on TZMT!
Telzuit Medical Technologies, Inc. Successfully Tests Functionality of STATPATCH Wireless Holter Monitor and Has Released the Product for Physician Testing
6:00a ET July 27, 2006 (PR NewsWire) Telzuit Medical Technologies, Inc. (OTC Bulletin Board: TZMT) announced today that it has successfully tested the functionality of the STATPATCH Wireless Holter Monitor and that the product is currently in physician testing with healthy volunteers. The testing is expected to last for several weeks, followed by the product rollout in Florida this year. The successful testing and physician release is the culmination of over five years of research and development in various areas of ambulatory cardiac monitoring and paves the way for the release of the Company's other wireless medical devices. The patent pending STATPATCH Wireless Heart Monitor is already FDA approved, and the Company expects to make additional FDA submissions over the next twelve months for other medical devices.
Warren Stowell, CEO of Telzuit, commented, "Today marks the beginning of the next phase of our product roll out. With the STATPATCH in the final stage of patient testing, we are very excited about the imminent release of our first product."
Looks like it's "GAME ON"
well, couldn't shareholders with margin accounts call for certs forcing those people who naked shorted to cover?
Yea, I wasn't very happy at first about tzmt changing management but, this guy seems like someone who speacializes in exactly what they need!Funding!!
This is what they say on tzmt's website about him :
Jerry Balter: CFO
Jerry Balter began his career in investment banking twenty-five years ago. During that time he has had extensive experience with mergers and acquisitions and public offerings and private placements of equity. Since 1986, he has worked exclusively with emerging growth companies. He has had experience with the venture capital world and venture capital-backed companies as an investor, operating officer (both as a CEO and as a finance officer), board member, investment banker, and most recently as a fund manager.
Jerry Balter has worked with biotechnology companies since 1986. He was a founder of ObeSys Ltd., Physiome Sciences, Inc. (now PrediX Pharmaceuticals), where he served as CEO until 1997, Professional Employer Services (a business services company) and Ramsay Managed Care (for an Australian entrepreneur). He has worked with a number of companies from formation stages through their public offering including Medicis Pharmaceutical, US BioSciences and Advanced Radio Telcom. Jerry’s expertise is in the area of equity financing, mergers & acquisitions and business strategy and has assisted over 25 private companies in obtaining financing.
I've done a little Google research on him...So far it seems that he is no joke!!
Hope not I'm holding quite a bit! LOL!!!
Fantastic! A new Cfo excels in patisserie? I love apple turnovers and strawberry scones. What do you like?
Mr. Balter, age 53, has more than 25 years of experience in investment baking.
This could confirm my believe that Tzmt is being shorted. From nasdaqtrader.com: Tzmt on Sho list.
As defined in Rule 203(c)(6) of Regulation SHO... where, for five consecutive settlement days:
. There are aggregate fails to deliver at a registered clearing agency of 10,000 shares or more per security;
. The level of fails is equal to at least one-half of one percent of the issuer's total shares outstanding; and
. The security is included on a list published by a self-regulatory organization (SRO).
A security ceases to be a threshold security if it does not exceed the specified level of fails for five consecutive settlement days.
Well, I believe Mms walk it up and down, pick up stops and limits along the way.
There sure is a lot of volume on TZMT recently.. it was fallen in value a lot in the past week... wonder what is going on here - more shorting? or is there something else going on here?
Naked shorting can exert detrimental effect on thinly traded stocks especially ones with low float. I thought Warren Stowell ought to know, if he's not already acknowledged about it.
Go to buyins.net and type in Tzmt on upper left hand corner. It should read On List as of 05/31/2006 Through 07/12/2006.
A case in point: Gte trading volume diminishes drastically since off list. Input Gte and you'd read Off List - 31 consecutive market days: Off List as of 05/26/2006 Through 07/12/2006.
Hope it helps.
Followers
|
5
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
222
|
Created
|
03/12/06
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |